In 4,285 women in Papua New Guinea who took their own vaginal sample for a point-of-care HPV test, 93% of those who tested positive were treated with thermal ablation the same day, and the strategy detected 85% of high-grade lesions.
HPV-STAT was a large single-arm intervention trial at two clinical sites in Papua New Guinea, from June 2018 to January 2020. Women aged 30 to 59 self-collected a vaginal specimen for point-of-care GeneXpert HPV testing; those who tested positive had a pelvic examination and same-day thermal ablation or referral. The authors call it the first real-world evaluation of a fully integrated self-collect, test and treat strategy for same-day cervical screening in a low- or middle-income country. Registered as ISRCTN13476702 and funded by Australia's National Health and Medical Research Council.
A woman in Papua New Guinea can take her own sample, get the result and, if needed, be treated in a single visit.
Shares National Department of Health, Papua New Guinea, HPV DNA testing and self-sampling, Cervical cancer.
Shares National Department of Health, Papua New Guinea, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/